Latest Articles

Publication Date
BioNTech's Trastuzumab Pamirtecan Achieves Positive Phase 2 Results in Advanced HER2-Expressing Endometrial Cancer - Quiver Quantitative

BioNTech's Trastuzumab Pamirtecan Achieves Positive Phase 2 Results in Advanced HER2-Expressing Endometrial Cancer Quiver Quantitative

Published: April 11, 2026, 11:10 a.m.
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer The Manila Times

Published: April 11, 2026, 11:01 a.m.
In recurrent endometrial cancer, BioNTech drug held off progression 8 months - Stock Titan

In recurrent endometrial cancer, BioNTech drug held off progression 8 months Stock Titan

Published: April 11, 2026, 11 a.m.
Progesterone in MHT for Protection Against Endometrial Cancer - The Vajenda

Progesterone in MHT for Protection Against Endometrial Cancer The Vajenda

Published: April 11, 2026, 9:17 a.m.
Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment - BioSpectrum Asia

Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment BioSpectrum Asia

Published: April 11, 2026, 7:52 a.m.
Natalie Githinji Moved to Tears by Fan’s Emotional Message on Her Digital Impact - Mpasho

Natalie Githinji Moved to Tears by Fan’s Emotional Message on Her Digital Impact Mpasho

Published: April 11, 2026, 6:46 a.m.
MP calls for urgent action on endometriosis diagnosis delays - The Argus

MP calls for urgent action on endometriosis diagnosis delays The Argus

Published: April 11, 2026, 4 a.m.
THE RIGHT TO REST: WHY SOUTH AFRICAN WOMEN SHOULD GET MENSTRUAL LEAVE - PressReader

THE RIGHT TO REST: WHY SOUTH AFRICAN WOMEN SHOULD GET MENSTRUAL LEAVE PressReader

Published: April 11, 2026, 12:01 a.m.
Reply of the authors: Trial emulation and clinical trials.

Published: April 11, 2026, midnight
Magnetic Resonance Imaging as a Non-Surgical Predictor of Endometriosis Fertility Index Surgical Factors.

Endometriosis affects 6%-10% of women of reproductive age and is associated with chronic pelvic pain, infertility, and impaired quality of life. The endometriosis fertility index (EFI) predicts spontaneous pregnancy postoperatively, …

Published: April 11, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!